Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradationHong Zhu, Hua Guo, Yun Guo et al.|Journal of Neuroinflammation|2023Cited by 35
Revealing rutaecarpine’s promise: A pathway to parkinson’s disease relief through PPAR modulationYeying Wang, Hong Zhu, H. Ye et al.|International Immunopharmacology|2025Cited by 3
Alpinetin Targets Mitophagy Pathways to Mitigate Parkinson's Disease ProgressionYayu Chen, Haijun Hu, Xuesong Shan et al.|CNS Neuroscience & Therapeutics|2025Cited by 2